Skip to main content
. Author manuscript; available in PMC: 2015 May 5.
Published in final edited form as: AIDS Res Hum Retroviruses. 2008 Mar;24(3):417–421. doi: 10.1089/aid.2007.0193

Figure 1. The frequency of CD163+/CD16+ monocytes is greater in patients with detectable viral loads.

Figure 1

The frequency of CD163+/CD16+ monocytes (CD14+) is significantly increased in HIV-1 infected individuals with detectable plasma viremia when compared to seronegative donors or patients with HIV-1 infection who are successfully controlling virus with pharmaceutical intervention. A slight reduction in the number of CD163+/CD16+ monocytes is seen with virus suppression as compared to seronegative individuals, however this is not statistically significant. All “undetectable” HIV-1 infected subjects were on ARV. Only a single donor within the “detectable” group was on ARV.